Healthcare Realty Trust AI Stock Analysis
Want to see HR full AI Analyst Report?
Healthcare Realty Trust (HR) AI Stock Analysis
Healthcare Realty Trust
(NYSE:HR)
The score reflects a balance of improving outlook and momentum versus weaker underlying GAAP profitability. The biggest positives are the strong, guidance-raising earnings call (higher FFO/NOI growth outlook, solid leasing/occupancy progress, and active buybacks) and constructive technical momentum. Offsetting these, financial performance is held back by net losses, sharply negative reported revenue growth, and higher leverage; valuation is mixed with a strong dividend yield but an unsupportive negative P/E.
Healthcare Realty Trust (HR) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $6.72B
- Dividend Yield
- 4.96%
- Average Volume (3M)
- 4.88M
- Price to Earnings (P/E)
- -136.1
- Beta (1Y)
- 0.11
- Revenue Growth
- -6.28%
- EPS Growth
- 77.63%
- Country
- US
- Employees
- 539
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- REIT - Healthcare Facilities
Healthcare Realty Trust Business Overview & Revenue Model
Company Description
Healthcare Realty Trust operates as a Real Estate Investment Trust (REIT), specializing in the acquisition, development, financing, and active management of income-generating real estate assets, predominantly serving outpatient healthcare providers t...
How the Company Makes Money
Healthcare Realty Trust makes money primarily through rental revenue generated by leasing its healthcare properties to tenants. Key revenue streams generally include: (1) Base rent under long-term leases with healthcare providers, physician groups, h...
Healthcare Realty Trust Earnings Call Summary
The call was strongly positive. Management reported solid operating performance, improving occupancy and leasing spreads, raised full-year guidance, maintained a flexible balance sheet, and continued disciplined share repurchases, acquisitions, and dispositions. The principal challenges were higher interest rates, potential transaction-volume moderation, uneven market conditions, higher redevelopment costs, and lower expected fourth-quarter absorption, but these issues were presented as manageable within an otherwise favorable operating environment.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Healthcare Realty raised full-year normalized FFO per share guidance to $1.65-$1.67, with a midpoint of $1.66, and raised full-year same-store cash NOI growth guidance to 5%-5.25%; sources and uses of capital increased by $85 million to reflect incremental share repurchases and JV acquisitions at share, while disposition guidance increased by the same amount. The company said guidance only reflects acquisitions, redevelopments, or other uses of capital announced to date, is going to keep trying to get cash leasing spreads in the 5% area, if not better, and expects its average disposition yield for the year to be in the mid-5% range; its $50 million-$100 million acquisition range remains applicable, leverage is consistent with the mid-5x target in its 2026 guidance, retention for 2027 expiring square footage is expected to be in the mid to high 80s, the SNO pipeline could bring same-store occupancy closer to 94%, total occupancy is trending towards right around 91%, and $40 million of the $50 million of NOI targeted for recapture is expected over the course of the three-year plan, more backend weighted.
Healthcare Realty Trust Financial Statement Overview
Summary
Operating metrics and cash generation are supportive (TTM EBITDA margin ~63% and positive TTM free cash flow of ~$168.6M), but overall results are constrained by persistent net losses (TTM net margin ~-4.0%), sharply negative reported revenue growth (-97.2%), and rising leverage (debt-to-equity ~1.10) with negative ROE.
Income Statement
34NegativeBalance Sheet
52NeutralCash Flow
63Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.13B | 1.18B | 1.27B | 1.34B | 932.64M | 534.82M |
| Gross Profit | 465.28M | -396.46M | -555.43M | -618.09M | -317.56M | -82.88M |
| EBITDA | 714.25M | 519.96M | 313.79M | 762.47M | 660.40M | 325.69M |
| Net Income | -44.93M | -246.07M | -654.49M | -278.26M | 40.90M | 66.66M |
Balance Sheet | ||||||
| Total Assets | 8.96B | 9.21B | 10.65B | 12.64B | 13.85B | 4.26B |
| Cash, Cash Equivalents and Short-Term Investments | 17.50M | 26.17M | 68.92M | 25.70M | 60.96M | 13.18M |
| Total Debt | 4.49B | 4.15B | 4.96B | 5.30B | 5.70B | 1.92B |
| Total Liabilities | 4.83B | 4.53B | 5.35B | 5.71B | 6.17B | 2.07B |
| Stockholders Equity | 4.08B | 4.62B | 5.23B | 6.82B | 7.57B | 2.19B |
Cash Flow | ||||||
| Free Cash Flow | 168.56M | 126.94M | 252.64M | 268.79M | 109.20M | 131.94M |
| Operating Cash Flow | 449.69M | 457.10M | 501.62M | 499.82M | 272.75M | 232.63M |
| Investing Cash Flow | 412.74M | 710.83M | 900.92M | 349.14M | 1.63B | -562.47M |
| Financing Cash Flow | -888.43M | -1.21B | -1.36B | -884.22M | -1.86B | 327.72M |
Healthcare Realty Trust Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HR, the sentiment is Positive. The current price of 19.36 is above the 20-day moving average (MA) of 18.66, above the 50-day MA of 18.00, and above the 200-day MA of 18.53, indicating a bullish trend. The MACD of 0.44 indicates Negative momentum. The RSI at 65.78 is Neutral, neither overbought nor oversold. The STOCH value of 63.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HR.
Healthcare Realty Trust Risk Analysis
Healthcare Realty Trust disclosed 42 risk factors in its most recent earnings report. Healthcare Realty Trust reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksHealthcare Realty Trust Peers Comparison
Overall Rating
CTRE77Outperform
NHI77Outperform
LTC75Outperform
SBRA72Outperform
HR65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $9.78B | 23.57 | 8.10% | 3.97% | 43.65% | 17.90% | |
| 77Outperform | $3.07B | 4.38 | 41.65% | 5.93% | 28.04% | 347.16% | |
| 75Outperform | $2.37B | 4.30 | 39.59% | 5.47% | 68.94% | 1200.88% | |
| 72Outperform | $5.40B | 73.64 | 2.55% | 5.82% | 21.20% | -61.51% | |
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| 65Neutral | $6.55B | -136.05 | -1.04% | 4.96% | -6.28% | 77.63% |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HR | Healthcare Realty Trust Incorporated | 19.36 | 2.70 | 16.21% | |
| LTC | Ltc Properties | 41.71 | 7.85 | 23.17% | |
| NHI | National Health Investors | 62.43 | -11.97 | -16.09% | |
| SBRA | Sabra Healthcare Reit | 20.62 | 3.13 | 17.90% | |
| CTRE | CareTrust REIT | 37.95 | 3.16 | 9.09% |
Healthcare Realty Trust Corporate Events
Healthcare Realty Trust Posts Q3 Loss, Lifts 2026 Guidance
PositiveHealthcare Realty Trust reported third-quarter 2026 results on October 29, 2026, posting a GAAP net loss of $0.05 per share but delivering NAREIT FFO of $0.38 per share, Normalized FFO of $0.42 per share and a 5.1% same-store cash NOI increase, suppo...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026
